---
figid: PMC7140057__cancers-12-00686-g005
figtitle: Molecular targeted therapy in uterine serous carcinoma
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC7140057
filename: cancers-12-00686-g005.jpg
figlink: pmc/articles/PMC7140057/figure/cancers-12-00686-f005/
number: F5
caption: Molecular targeted therapy in uterine serous carcinoma. Reported drugs targeting
  the PI3K/AKT/mTOR signaling pathway, cell cycle regulation, and the PD-1/PD-L1 pathway
  are under clinical investigation for the treatment of patients with uterine serous
  carcinoma.
papertitle: Pathogenesis and Clinical Management of Uterine Serous Carcinoma.
reftext: Li Zhang, et al. Cancers (Basel). 2020 Mar;12(3):686.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9268964
figid_alias: PMC7140057__F5
figtype: Figure
redirect_from: /figures/PMC7140057__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7140057__cancers-12-00686-g005.html
  '@type': Dataset
  description: Molecular targeted therapy in uterine serous carcinoma. Reported drugs
    targeting the PI3K/AKT/mTOR signaling pathway, cell cycle regulation, and the
    PD-1/PD-L1 pathway are under clinical investigation for the treatment of patients
    with uterine serous carcinoma.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - DCLK1
  - ADGRL1
  - CLU
  - AKR1C4
  - GZMB
  - POLR3K
  - CCNB1
  - CCNB2
  - CCNB3
  - WARS1
  - ERBB2
  - CDKL1
  - CDKL2
  - CDKL3
  - CDKL4
  - CDKL5
  - CDK3
  - CDK4
  - CDK5
  - CDK6
  - CDK7
  - CDK8
  - CDK9
  - CDK10
  - CDK11A
  - CDK11B
  - CDK12
  - CDK13
  - CDK14
  - CDK15
  - CDK16
  - CDK17
  - CDK18
  - CDK19
  - CDK20
  - CDK1
  - CDK2
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - NEU1
  - NEURL1
  - CD274
  - CCNE1
  - CCNE2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MTOR
  - RPTOR
  - AKT1
  - AKT2
  - AKT3
  - TP53
  - TP63
  - TP73
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - HDAC9
  - HDAC1
  - HDAC2
  - HDAC3
  - HDAC8
  - HDAC4
  - HDAC5
  - HDAC7
  - HDAC6
  - HDAC10
  - SIRT1
  - SIRT2
  - SIRT3
  - SIRT4
  - SIRT5
  - SIRT6
  - SIRT7
  - HDAC11
  - C15
  - Cli
  - eya
  - CycB
  - anon-70Dc
  - LanB2
  - anon-70Db
  - Cdk4
  - Nrt
  - neur
  - CycE
  - Cdk2
  - et
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Crtc
  - Akt
  - p53
  - betaTub60D
  - hth
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - lapatinib
  - GDC-0941
  - ZSTK474
  - BAY80-6946
  - LY3023414
  - NVP
  - BEZ235
  - MK-2206
  - AZD8055
  - gefitinib
  - paclitaxel
---
